02000nas a2200217   4500000000100000008004100001260003400042653002400076653005700100653002100157653001700178100001300195700001600208700001400224700001200238700001100250245008800261856010400349520130400453022002501757       2022                            d  bOxford University Press (OUP)10aInfectious Diseases10aPublic Health, Environmental and Occupational Health10aGeneral Medicine10aParasitology1 aAhmed SA1 aEl-Sobky TA1 ade Hoog S1 aZaki SM1 aTaha M00aA scoping review of mycetoma profile in Egypt: revisiting the global endemicity map  uhttps://academic.oup.com/trstmh/advance-article-pdf/doi/10.1093/trstmh/trac085/45764174/trac085.pdf3 a<p>Mycetoma is a chronic infectious disease endemic in sub-Saharan Africa (SSA), India and parts of South and North America. The epidemiologic profile of the disease in Egypt, which neighbours SSA, has not been explored previously. Therefore we conducted a scoping review of the literature on mycetoma in Egypt. We searched the literature comprehensively on MEDLINE and Google Scholar using free-text words and Medical Subject Headings and terms. Both published and non-peer-reviewed (grey literature) articles were included. The initial search identified 133 reports. Of these, only eight were found to be relevant and were included in the study. The total number of mycetoma patients was 59, reported between 1949 and 2015. There was a predilection for eumycetoma (44 of 59) patients (75%), while actinomycetoma constituted 15 patients (25%). Six patients were female, 28 were male and 25 were unreported. Children and adolescents constituted 3 of 59 (5%), 52 (88%) were adults and age was not provided for 4 patients. Only four patients (7%) were non-autochthonous. The incidence of mycetoma in Egypt is higher than previously reported. Egypt is probably a low-endemic country. An accurate estimate of the prevalence and epidemiology of mycetoma necessitates further research collaboration.</p>
  a0035-9203, 1878-3503